John E. Kao, Chief Executive Officer at Alignment Healthcare, Inc. (ALHC), sold 180,000 shares at $17.29 ($3.1M) on 2025-10-10, disclosed to the SEC on 2025-10-14.
Scheduled sale ($3.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALHC | SELL | 2026-08-10 | $4.1M | — | Filing → |
| ALHC | SELL | 2026-07-14 | $5.9M | — | Filing → |
| ALHC | SELL | 2026-06-12 | $6.1M | — | Filing → |